US6029661A
(en)
*
|
1991-08-26 |
2000-02-29 |
3M Innovative Properties Company |
Powder dispenser
|
GB9203761D0
(en)
*
|
1992-02-21 |
1992-04-08 |
Innovata Biomed Ltd |
Inhaler
|
ATE142515T1
(de)
*
|
1992-06-05 |
1996-09-15 |
Hoechst Ag |
Inhalator
|
GB9212670D0
(en)
*
|
1992-06-15 |
1992-07-29 |
Norton Healthcare Ltd |
An inhaler
|
US5394868A
(en)
*
|
1992-06-25 |
1995-03-07 |
Schering Corporation |
Inhalation device for powdered medicaments
|
EP0674533B1
(de)
*
|
1992-12-18 |
1999-03-10 |
Schering Corporation |
Inhalator für pulverförmige medikamente
|
GB9326574D0
(en)
*
|
1993-12-31 |
1994-03-02 |
King S College London |
Dry power inhalers
|
DE19505341C2
(de)
*
|
1995-02-17 |
1996-12-12 |
Gsf Forschungszentrum Umwelt |
Gerät zur Auftrennung des Teilchengrößenspektrums eines polydispersen Aerosols
|
US5483953A
(en)
*
|
1995-04-08 |
1996-01-16 |
The United States Of America As Represented By The Secretary Of The Navy |
Aerosol dispensing apparatus for dispensing a medicated vapor into the lungs of a patient
|
US5474059A
(en)
*
|
1995-04-08 |
1995-12-12 |
Cooper; Guy F. |
Aerosol dispensing apparatus for dispensing a medicated vapor into the lungs of a patient
|
US5645051A
(en)
*
|
1995-04-21 |
1997-07-08 |
Dura Pharmaceuticals, Inc. |
Unit dose dry powder inhaler
|
PL182198B1
(en)
*
|
1995-06-21 |
2001-11-30 |
Asta Medica Ag |
Pharmaceutic powder holding container with integrated measuring device and powdered
|
JP3317823B2
(ja)
|
1995-08-11 |
2002-08-26 |
株式会社ユニシアジェックス |
投薬器
|
SE9700936D0
(sv)
*
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Inhalation device
|
SE9700937D0
(sv)
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Powder inhaler I
|
SE9700940D0
(sv)
*
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Powder inhaler IV
|
TW469832U
(en)
|
1997-03-14 |
2001-12-21 |
Astra Ab |
Inhalation device
|
NL1006058C2
(nl)
*
|
1997-05-14 |
1998-11-17 |
R & D Injector Ag |
Doseerinrichting.
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
US7305986B1
(en)
|
1999-07-23 |
2007-12-11 |
Mannkind Corporation |
Unit dose capsules for use in a dry powder inhaler
|
US7464706B2
(en)
|
1999-07-23 |
2008-12-16 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
GB0019715D0
(en)
|
2000-08-10 |
2000-09-27 |
Pa Consulting Services |
Device for delivering physiologically active agent in powdered form
|
GB2375960A
(en)
*
|
2001-05-30 |
2002-12-04 |
Shih-Ho Chang |
An apparatus for the administration of medicine to the respiratory tract
|
US6681768B2
(en)
|
2001-06-22 |
2004-01-27 |
Sofotec Gmbh & Co. Kg |
Powder formulation disintegrating system and method for dry powder inhalers
|
DE10202940A1
(de)
|
2002-01-24 |
2003-07-31 |
Sofotec Gmbh & Co Kg |
Patrone für einen Pulverinhalator
|
US7258118B2
(en)
|
2002-01-24 |
2007-08-21 |
Sofotec Gmbh & Co, Kg |
Pharmaceutical powder cartridge, and inhaler equipped with same
|
SI1494732T1
(sl)
|
2002-03-20 |
2008-08-31 |
Mannking Corp |
Inhalacijski aparat
|
DE10244795A1
(de)
|
2002-09-26 |
2004-04-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverinhalator
|
FR2849386B1
(fr)
*
|
2002-12-27 |
2005-03-18 |
Bertin Technologies Sa |
Dispositif d'inhalation de poudre seche
|
EP1488819A1
(de)
|
2003-06-16 |
2004-12-22 |
Rijksuniversiteit te Groningen |
Trockenpulverinhalator und Verfahren zur pulmonalen Inhalation von Trockenpulver
|
CA2562386C
(en)
|
2004-04-21 |
2014-11-18 |
Innovata Biomed Limited |
Inhaler
|
NZ551670A
(en)
|
2004-05-31 |
2010-07-30 |
Almirall Lab |
Combinations comprising antimuscarinic agents and corticosteroids
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
NZ552523A
(en)
|
2004-07-16 |
2010-11-26 |
Almirall Sa |
Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler
|
CN101010305B
(zh)
|
2004-08-20 |
2010-08-11 |
曼金德公司 |
二酮哌嗪合成的催化反应
|
EP2314298B1
(de)
|
2004-08-23 |
2015-05-27 |
MannKind Corporation |
Mikropartikel enthaltend Diketopiperazinsalze zur Arzneimitteldarreichung
|
ES2265276B1
(es)
|
2005-05-20 |
2008-02-01 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
US8763605B2
(en)
|
2005-07-20 |
2014-07-01 |
Manta Devices, Llc |
Inhalation device
|
RU2390325C2
(ru)
|
2005-09-14 |
2010-05-27 |
Маннкайнд Корпорейшн |
Способ приготовления лекарственного препарата, основанный на увеличении сродства активных агентов к поверхностям кристаллических микрочастиц
|
JP5599975B2
(ja)
|
2006-02-22 |
2014-10-01 |
マンカインド コーポレイション |
ジケトピペラジン及び活性薬剤を含有する微粒子の製剤特性の改善方法
|
ATE540717T1
(de)
|
2006-12-22 |
2012-01-15 |
Almirall Sa |
Inhalationsvorrichtung für arzneimittel in pulverform
|
ES2306595B1
(es)
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
CN101795723B
(zh)
|
2007-07-06 |
2013-06-19 |
蒙塔设备有限公司 |
用于存储和输送药物的吸入装置
|
US11224704B2
(en)
|
2007-07-06 |
2022-01-18 |
Manta Devices, Llc |
Dose delivery device for inhalation
|
ES2320961B1
(es)
|
2007-11-28 |
2010-03-17 |
Laboratorios Almirall, S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
|
CA2709071C
(en)
|
2007-12-14 |
2016-11-15 |
Labogroup S.A.S. |
Delivering aerosolizable food products
|
EP2096105A1
(de)
|
2008-02-28 |
2009-09-02 |
Laboratorios Almirall, S.A. |
4-(2-Amino-1-hydroxyethyl)Phenol-Derivate als Agonisten des b2-adrenergen Rezeptors
|
EP2100599A1
(de)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
|
EP2100598A1
(de)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
|
EP2108641A1
(de)
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
Neue substituierte Spiro[Cycloalkyl-1,3'-indo]-2'(1'H)-on-Derivate und ihre Verwendung als p38 mitogen-activated Kinase Inhibitoren
|
EP2113503A1
(de)
|
2008-04-28 |
2009-11-04 |
Laboratorios Almirall, S.A. |
Neue substituierte Indolin-2-on- Derivate und ihre Verwendung als p39 mitogen-activated Kinase Inhibitoren
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
CA3153292A1
(en)
|
2008-06-13 |
2009-12-17 |
Mannkind Corporation |
A dry powder inhaler and system for drug delivery
|
CN103751892B
(zh)
|
2008-06-20 |
2017-03-01 |
曼金德公司 |
用于对吸入工作进行实时描绘的交互式设备和方法
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
EP2196465A1
(de)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea-Derivate als PDE4 Hemmern
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
EP2221297A1
(de)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-Difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on und seine Verwendung bei der Behandlung von Atemwegserkrankungen
|
EP2221055A1
(de)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one für die Behandlung von Lungenfunktion
|
EP2226323A1
(de)
|
2009-02-27 |
2010-09-08 |
Almirall, S.A. |
Neuartige Tetrahydropyrazol[3,4-c]isochinolin-5-amin-Derivate
|
PL2405963T3
(pl)
|
2009-03-11 |
2014-04-30 |
Mannkind Corp |
Urządzenie, układ i sposób pomiaru oporu inhalatora
|
EP2228368A1
(de)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Verfahren zur Herstellung von 5-(2-{[6-(2,2-Difluor-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on
|
WO2010144789A2
(en)
|
2009-06-12 |
2010-12-16 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
EP2322176A1
(de)
|
2009-11-11 |
2011-05-18 |
Almirall, S.A. |
Neue 7-Phenyl-[1,2,4]triazol[4,3-a]pyridin-3(2H)on-Derivate
|
EP2380890A1
(de)
|
2010-04-23 |
2011-10-26 |
Almirall, S.A. |
Neue 7,8-Dihydro-1,6-Naphthyridin-5(6H)-on-Derivate als PDE4 Inhibitoren
|
EP2386555A1
(de)
|
2010-05-13 |
2011-11-16 |
Almirall, S.A. |
Neue Cyclohexylaminderivate mit Aktivitäten von Beta2-adrenergem Agonisten und M3-Muskarin-Antagonisten
|
EP2394998A1
(de)
|
2010-05-31 |
2011-12-14 |
Almirall, S.A. |
3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl Derivate als PDE4 Inhibitoren
|
CN102985125A
(zh)
|
2010-06-21 |
2013-03-20 |
曼金德公司 |
干粉药物输送系统和方法
|
EP2441755A1
(de)
|
2010-09-30 |
2012-04-18 |
Almirall, S.A. |
Pyridin- und Isochinolin-Derivate als Syk- und JAK-Kinase-Inhibitors
|
EP2457900A1
(de)
|
2010-11-25 |
2012-05-30 |
Almirall, S.A. |
Neue Pyrazolderivate mit CRTH2-antagonistischem Verhalten
|
EP2463289A1
(de)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]Pyridazin-Derivate als AS JAK-Hemmer
|
EP2489663A1
(de)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Verbindungen als Syk-Kinasehemmer
|
AU2012236150B2
(en)
|
2011-04-01 |
2016-03-31 |
Mannkind Corporation |
Blister package for pharmaceutical cartridges
|
EP2510928A1
(de)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
|
EP2518071A1
(de)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridinderivate als PI3K-Inhibitoren
|
EP2518070A1
(de)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Pyrrolotriazinonderivate als PI3K-Inhibitoren
|
EP2526945A1
(de)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Neue CRTH2-Antagonisten
|
EP2527344A1
(de)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Als Medikamente zur Behandlung von myeloproliferativen Krankheiten, Transplantatabstossung, immunbedingten und entzündlichen Erkrankungen geeignete Pyridin-2(1H-)-on-Derivate
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
EP2548876A1
(de)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
Neue CRTH2-Antagonisten
|
EP2548863A1
(de)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
Neue CRTH2-Antagonisten
|
EP2554544A1
(de)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Pyridin-2(1H-)-on-Derivate als JAK-Inhibitoren
|
CA2846899C
(en)
|
2011-09-07 |
2019-12-03 |
Syphase, Llc |
Dry powder inhalation device
|
EP2578570A1
(de)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Neues Verfahren zur Herstellung von 5-(2-{[6-(2,2-Difluor-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxychinolin-2(1H)-on mittels neuen Synthesezwischenstoffen
|
IN2014DN03093A
(de)
|
2011-10-24 |
2015-05-15 |
Mannkind Corp |
|
EP2592077A1
(de)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
Neue Cyclohexylaminderivate mit Aktivitäten von Beta2-adrenergem Agonisten und M3-Muskarin-Antagonisten
|
EP2592078A1
(de)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
Neue Cyclohexylaminderivate mit Aktivitäten von Beta2-adrenergem Agonisten und M3-Muskarin-Antagonisten
|
EP2641900A1
(de)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Neuartige polymorphe Kristallformen von 5-(2-{[6-(2,2-difluor-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on, Heminapadisylat als Agonist des beta2-adrenergen Rezeptors
|
EP2647627A1
(de)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Salze von 5-[(1r)-(2-{[4-(2,2-difluor-2-phenylethoxy)phenyl].ethyl}amino}-1- hydroxyethyl)-8-hydroxychinolin-2(1H)-on.
|
EP2666465A1
(de)
|
2012-05-25 |
2013-11-27 |
Almirall, S.A. |
Neuartige Dosierung und Formulierung
|
EP2668941A1
(de)
|
2012-05-31 |
2013-12-04 |
Almirall, S.A. |
Neue Darreichungsform und Formulierung von Abediterol
|
EP2872205B1
(de)
|
2012-07-12 |
2017-02-08 |
MannKind Corporation |
System zur verabreichung von arzneimitteln in trockenpulverform
|
WO2014060431A1
(en)
|
2012-10-16 |
2014-04-24 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
EP2738172A1
(de)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
Neue bizyklische Verbindungen als CRAC-Kanalmodulatoren
|
JP6307091B2
(ja)
|
2012-12-18 |
2018-04-04 |
アルミラル・ソシエダッド・アノニマAlmirall, S.A. |
β2アドレナリンアゴニスト活性およびM3ムスカリンアンタゴニスト活性を有する新規のシクロヘキシルおよびキヌクリジニルカルバメート誘導体
|
UY35332A
(es)
|
2013-02-15 |
2014-11-28 |
Almirall Sa |
Derivados de pirrolotriazina como inhibidores de pi3k
|
US9764890B2
(en)
|
2013-03-04 |
2017-09-19 |
Vega Innovations Pty Ltd |
Liquid spray dispenser system
|
SG10201708090TA
(en)
|
2013-03-15 |
2017-11-29 |
Mannkind Corp |
Microcrystalline diketopiperazine compositions and methods
|
EP2848615A1
(de)
|
2013-07-03 |
2015-03-18 |
Almirall, S.A. |
Neue Pyrazolderivate als CRAC-Kanalmodulatoren
|
KR102321339B1
(ko)
|
2013-07-18 |
2021-11-02 |
맨카인드 코포레이션 |
열-안정성 건조 분말 약제학적 조성물 및 방법
|
EP3030294B1
(de)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflationsvorrichtung
|
WO2015091287A1
(en)
|
2013-12-19 |
2015-06-25 |
Almirall S.A. |
Dosage formulation comprising salmeterol and fluticasone propionate
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
WO2015168572A2
(en)
|
2014-05-02 |
2015-11-05 |
Manta Devices, Llc |
Delivery device and related methods
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US10214509B2
(en)
|
2015-04-21 |
2019-02-26 |
Almirall, S.A. |
Amino-substituted heterocyclic derivatives as sodium channel inhibitors
|
WO2016202800A1
(en)
|
2015-06-16 |
2016-12-22 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
WO2017076990A1
(en)
|
2015-11-05 |
2017-05-11 |
Almirall, S.A. |
Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide
|
DE202016008123U1
(de)
|
2016-10-26 |
2017-03-09 |
Meister Eber GmbH |
Inhalationsvorrichtung mit einer Kapsel
|
CN110494181B
(zh)
|
2017-03-28 |
2022-03-18 |
康森特里克斯药物公司 |
用于输送干粉药物的装置和方法
|
TW201919682A
(zh)
|
2017-08-08 |
2019-06-01 |
西班牙商阿爾米雷爾有限公司 |
活化Nrf2路徑的新穎化合物
|
WO2021111184A1
(en)
*
|
2019-12-04 |
2021-06-10 |
Diag-Nose Medical Pty Ltd |
A method and apparatus for respiratory secretion collection and analysis
|
US11628263B2
(en)
*
|
2020-03-02 |
2023-04-18 |
Peter Daniel Klurfeld |
Tri-state compact modular inhaler, vaporizer
|
DE102020113812A1
(de)
|
2020-05-22 |
2021-11-25 |
Medic Activ Vertriebs Gmbh |
Transportgesicherte permanent offene Wechselkartusche zur Aerosolerzeugung
|
DE102022102946A1
(de)
|
2022-02-08 |
2023-08-10 |
Hatchmore Labs GmbH |
Nasenapplikator
|